Antoinette S. Gomes, MD, FAHA, FSIR
Institutional Affiliation
Education
Fellowships
Internship
Degree
Residencies
Board Certification
Contact Information
Phone
Clinical Interests
Scientific Interests
Dr. Antoinette Gomes' research interests include:
- Locoregional treatment of primary and secondary liver cancer (hepatocellular carcinoma, colorectal, neuroendocrine, etc.);
- Uterine cancer and benign tumors of the uterus; and
- Angiosarcoma and benign tumors and malformations of the vascular system.
Highlighted Publications
Gomes AS, Monteleone PA, Sayre JW, Finn RS, Sadeghi S, Tong MJ, Britten CD, Busuttil RW. Comparison of Triple-Drug Transcatheter Arterial Chemoembolization (TACE) With Single-Drug TACE Using Doxorubicin-Eluting Beads: Long-Term Survival in 313 Patients. AJR Am J Roentgenol. 2017 Oct;209(4):722-732. doi: 10.2214/AJR.17.18219. Epub 2017 Jul 13.
Britten CD, Gomes AS, Wainberg ZA, Elashoff D, Amado R, Xin Y, Busuttil RW, Slamon DJ, Finn RS. Transarterial chemoembolization plus or minus intravenous bevacizumab in the treatment of hepatocellular cancer: a pilot study. BMC Cancer. 2012 Jan 14;12:16. doi: 10.1186/1471-2407-12-16.
Gomes AS, Rosove MH, Rosen PJ, Amado RG, Sayre JW, Monteleone PA, Busuttil RW. Triple-drug transcatheter arterial chemoembolization in unresectable hepatocellular carcinoma: assessment of survival in 124 consecutive patients. AJR Am J Roentgenol. 2009 Dec;193(6):1665-71. doi: 10.2214/AJR.08.1806.